A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes

NCT00001062 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

Cytomegalovirus Retinitis
HIV Infections

Interventions

DRUG: Ganciclovir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)